Navigation Links
China Osteoporosis Drug Market 2013 Analysis & 2017 Forecasts in New Research Report at ChinaMarketResearchReports.com
Date:11/11/2013

Dallas, TX (PRWEB) November 12, 2013

Osteoporosis is a systemic bone disease, a common disease among middle and old-aged people. It is characterized by low bone mineral density and deterioration of bone microarchitecture, which can lead to increased risks of fragility fracture. There are over 200 million osteoporosis patients around the world in the current stage. Regarding the genders of osteoporosis patients, the number of female patients is much larger than that of male patients, and the former are attacked by osteoporosis much earlier than the latter.

According to the data of Ministry of Civil Affairs of China, by the end of 2012, the population that were 60 years old and above was 193.9 million, taking up 14.3% of the total population; the population that were 65 years old and above was 127.14 million, taking up 9.4%. China has the largest old-aged population around the world, and the incidence rate of osteoporosis keeps increasing year after year. The number of patients diagnosed with osteoporosis in China is over 70 million, and the number of female patients is triple as much as that of male patients. 40%-50% patients are 60 years old or above, and about 25% patients have suffered fractures because of osteoporosis. The incidence of fracture, pain and deformation of spinal column keeps increasing.

Complete report is available @ http://www.chinamarketresearchreports.com/114662.html .

More than 30 kinds of osteoporosis drugs have been launched into the market in the world. Clinically, bisphosphonates, parathyroid hormones, selective estrogen receptor modulators and activated vitamin D and analogues are used most often, which is the same as the situation in China. However, some newly launched osteoporosis drugs overseas are not launched in China yet, such as bazedoxifene acetate, eldecalcitol and some prolonged action preparations of bisphosphonates.

In 2012, the global market size of 6 kinds of osteoporosis drugs was each over USD 1 billion. Top 3 drugs all belong to bisphosphonates: zoledronic acid, risedronate sodium and alendronate sodium. The market size of zoledronic acid is the largest, about USD 2 billion.

During 2008-2012, bisphosphonates, activated vitamin D and analogues, and calcitonins always took up above 98% shares of China osteoporosis drug market. The market share of bisphosphonates increased at the highest speed; that of activated vitamin D and analogues remained stable; that of calcitonins significantly decreased since 2011.

During 2008-2012, regarding the osteoporosis drugs in China hospital market, the market size of osteoporosis drugs of Jiangsu Hengrui Medicine Co., Ltd. increased at the highest speed, and CAGR (compound average growth rate) was 42.4%; the growth rate of Qingdao Chiatai Haier Pharmaceutical Co., Ltd. ranked the second, and CAGR was 36.1%; CAGR of Novartis was 33%, in spite of its large base figure. Therefore, Novartis is the most excellent enterprise.

With the increasingly serious problem of aging of population, the number of osteoporosis patients increases at high speed accordingly. It is predicted that there will be over 200 million patients by 2050. For global pharmaceutical enterprises, they will find huge market opportunities in China.

Through this report, the readers can acquire the following information:

  •     Incidence status of osteoporosis
  •     Supply and demand status of osteoporosis drugs in China
  •     Market status of sub-varieties of osteoporosis drugs
  •     Competition status of China market
  •     Market opportunities of osteoporosis drugs in China

The following enterprises and people are proposed to purchase this report:

  •     Pharmaceutical enterprises
  •     Medicine trading enterprises
  •     Medical Institutions
  •     Investors/research institutes concerned about China pharmaceutical market

Purchase a copy of this report @ http://www.chinamarketresearchreports.com/contacts/purchase.php?name=114662 .

Browse more reports on Life Sciences Industry @ http://www.chinamarketresearchreports.com/cat/life-sciences.html .

About Us:
ChinaMarketResearchReports.com (http://www.chinamarketresearchreports.com/ .) is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/china-osteoporosis-drug/industry-2013-2017/prweb11320746.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. China Injection Moulding Factory DuratecPlastics.com Unveils Its New Collection Of Plastic Moulds For Electronic Parts
2. Dental Care Market in China 2012-2016: Worldwide Latest Market Share, Investment Trends, Growth, Size, Strategy And Forecast Research
3. Casket Wholesale from China Casket Manufacturer MillionaireCasket.com
4. China Plastic Injection Molding Company DuratecPlastics.com: Cheap Plastic Designs For November
5. Research and Development Forecast of China’s Water Purifier Industry, 2013-2017
6. New and High Quality Men’s Clothes Online from China’s Reliable Supplier, 4leafcity.com
7. China Plastic Injection Moulding Company DuratecPlastics.com Adds 28 Items To Its Product Line
8. Report on China’s Raw Milk Powder Market Supply and Demand
9. CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China
10. China Plastic Injection Mould Company DuratecPlastics.com Announces Great Discounts on its Custom 3D Mould Designs
11. Globalsurance Releases New Article on Health Concerns in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
Breaking Medicine Technology: